Abstract:To the Editor: We congratulate Yi and colleagues1Yi S. Huang Y. Yu S.Z. Chen X.J. Yi H. Zeng X.L. Therapeutic effect of atropine 1% in children with low myopia.J AAPOS. 2015; 19: 426-429Abstract Full Text Full Text PDF PubMed Scopus (47) Google Scholar on their successful use of atropine 1% to control myopia, which is rare in mainland China. However, there are several questions to address. First, the authors indicate that 6 patients (8%) withdrew from the treatment group and 2 (3%) from the control group, but Table 1 indicates that 68 subjects are in the treatment group and 64 in normal group withdrew. Second, there was a reduction of myopia by −0.32 ± 0.22 D in the atropine group; in addition, the axial length was −0.03 ± 0.07 mm compared with baseline after 1 year. Atropine has been much discussed recently and has been reported to effectively control myopia2Shih K.C. Chan T.C. Ng A.L. et al.Use of atropine for prevention of childhood myopia progression in clinical practice.Eye Contact Lens. 2016; 42: 16-23Crossref PubMed Scopus (27) Google Scholar; however, this report suggests that it can even reverse myopia, as indicated by the authors’ Figures 2 and 3. These results are surprising, and we wonder how and why this was possible? Third, atropine has been reported to have dose-related side effects, although none were reported in this research: 1% atropine is a relatively high dose, and adverse effects might be expected. Therefore, data on accommodation amplitude, near vision and, low-dose atropine treatment would be helpful.3Chia A. Lu Q.S. Tan D. Five-Year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01% eyedrops.Ophthalmology. 2016; 123: 391-399Abstract Full Text Full Text PDF PubMed Scopus (310) Google Scholar Finally, the authors assert in their discussion that uncorrected distance visual acuity in 35 of 68 patients in the atropine group was ≤0.3 (20/40). These 35 patients should be able to see clearly without glasses for most tasks. However, for children 7-12 years of age, visual acuity ≤0.3 is below normal and glasses may be important. Photophobia could also be a problem requiring the use of photochromatic glasses. Therapeutic effect of atropine 1% in children with low myopiaJournal of American Association for Pediatric Ophthalmology and Strabismus {JAAPOS}Vol. 19Issue 5PreviewTo evaluate the efficacy of topical atropine 1% in promoting unaided visual acuity, reducing myopia, and slowing the progression of ocular axial elongation in Chinese children with low myopia. Full-Text PDF

Effectiveness 0.05% Atropine for Controlling Myopia Progression in School Going Children

Effect of atropine 0.01% on progression of myopia

Myopia Controlling using Low Dose Atropine Eye Drop

Efficacy and Safety of Low Dose Atropine 0.01% in Slowing of Progression of Myopia

Myopia Control in Caucasian Children with 0.01% Atropine Eye Drops: 1-Year Follow-Up Study

Short-term Effect of 0.01% Atropine Sulphate Eye Gel on Myopia Progression in Children.

Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression

Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial

Effective Decrease in Myopia Progression With Two Mechanisms of Management

Efficacy of atropine for myopia control in children: A meta-analysis of randomized controlled trials

Effects of Atropine 0.01% on Refractive Errors in Children with Myopia.

Efficacy and Safety of 1% Atropine on Retardation of Moderate Myopia Progression in Chinese School Children

Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials.

Five-year results of atropine 0.01% efficacy in the myopia control in a European population

Analysis of Factors That May Affect the Effect of Atropine 0.01% on Myopia Control.

Low-dose atropine 0.01% for the treatment of childhood myopia: a pan-India multicentric retrospective study

Myopia outcome study of atropine in children: Two-year result of daily 0.01% atropine in a European population

Side effects of topical atropine 0.05% compared to 0.01% for myopia control in German school children: a pilot study

Therapeutic Effect of Atropine 1% in Children with Low Myopia.

Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children — a prospective, randomized, double-masked, and crossover trial

Efficacy and Safety of Consecutive Use of 1% and 0.01% Atropine for Myopia Control in Chinese Children: the Atropine for Children and Adolescent Myopia Progression Study